Workflow
科华转债
icon
Search documents
上海科华生物工程股份有限公司关于2025年第三季度可转债转股情况的公告
登录新浪财经APP 搜索【信披】查看更多考评等级 ■ 上海科华生物工程股份有限公司 关于2025年第三季度可转债转股情况的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗 漏。 特别提示: ■ 根据《深圳证券交易所股票上市规则》、《深圳证券交易所上市公司自律监管指引第15号一一可转换公 司债券》的有关规定,上海科华生物工程股份有限公司(以下简称"公司")现将2025年第三季度可转换 公司债券(以下简称"可转债")转股及公司股份变动情况公告如下: 一、可转债发行上市基本情况 1、可转债发行情况 经深圳证券交易所"深证上[2020]731号"文同意,公司73,800.00万元可转债于2020年8月20日起在深圳证 券交易所挂牌交易,债券简称"科华转债",债券代码"128124"。 3、可转债转股期限 根据《上海科华生物工程股份有限公司公开发行可转换公司债券募集说明书》(以下简称"《募集说明 书》"),本次发行的可转债转股期自可转债发行结束之日(2020年8月3日)满六个月后的第一个交易 日(2021年2月3日)起至可转债到期日(2026年7月27日)止。 4、可转债 ...
科华转债回售结果公布,70张回售金额7016.87元
Xin Lang Cai Jing· 2025-09-17 08:47
Core Viewpoint - Shanghai Kehua Bio-engineering Co., Ltd. announced the results of the "Kehua Convertible Bond" repurchase, indicating a low level of investor participation in the repurchase process [1] Group 1: Repurchase Details - The repurchase application period for the "Kehua Convertible Bond" (bond code: 128124) is from September 10 to September 16, 2025 [1] - The repurchase price is set at 100.241 yuan per bond (including interest and tax) [1] - The total number of valid applications received at the end of the application period was 70 bonds, amounting to 7016.87 yuan (including interest and tax) [1] Group 2: Financial Impact - The funds from the issuer will be credited on September 19, with the repurchase amount being allocated on September 22, and investors will receive the funds on September 23 [1] - This repurchase will have no significant impact on the company's financials [1] - The unrepurchased "Kehua Convertible Bonds" will continue to be traded on the Shenzhen Stock Exchange [1]
上海科华生物工程股份有限公司 关于“科华转债”回售的第六次提示性公告
Core Viewpoint - The company announces the conditional redemption of its convertible bonds, "Kehua Convertible Bonds," with specific terms and conditions for bondholders to exercise their redemption rights [1][2][3]. Redemption Overview - Redemption Price: 100.241 RMB per bond (including interest and tax) [1][6]. - Trigger Date for Redemption Conditions: September 5, 2025 [1]. - Redemption Period: September 10 to September 16, 2025 [2][9]. - Payment Dates: Funds will be credited to the company on September 19, 2025, with redemption payments to investors on September 23, 2025 [2][9]. Redemption Conditions - The redemption clause is activated if the company's stock price remains below 70% of the conversion price (14.45 RMB) for 30 consecutive trading days [1][12]. - Bondholders can redeem all or part of their unconverted bonds, and the redemption is not mandatory [7][12]. Interest Calculation - The interest for the current period is calculated as follows: IA = B × i × t / 365, where B is the total face value of the bonds, i is the annual coupon rate (2.00%), and t is the number of days from the last interest payment to the start of the redemption period [4][5]. - The calculated interest per bond is 0.241 RMB, leading to a total redemption price of 100.241 RMB per bond [5][6]. Redemption Process - Bondholders must submit their redemption requests through the Shenzhen Stock Exchange trading system during the specified redemption period [9]. - The company will announce the results of the redemption and its impact on the company after the redemption period ends [9]. Suspension and Resumption of Conversion - The conversion of "Kehua Convertible Bonds" will be suspended during the redemption period (September 10 to September 16, 2025) and will resume on September 17, 2025 [11][12].
上海科华生物工程股份有限公司关于“科华转债”回售的第五次提示性公告
Core Points - The company announced the conditional redemption of its convertible bonds, "Kehua Convertible Bonds," with a redemption price of 100.241 RMB per bond, including interest and tax [1][7] - The redemption condition is triggered if the company's stock price falls below 70% of the conversion price for 30 consecutive trading days, specifically below 14.45 RMB per share [1][4] - The redemption period is set from September 10, 2025, to September 16, 2025, with the funds being transferred to bondholders by September 23, 2025 [2][10] Redemption Terms - The redemption price consists of the bond's face value plus accrued interest, calculated based on a 2.00% annual interest rate for the sixth interest period [5][6] - The accrued interest for the redemption period is calculated to be 0.241 RMB per bond, leading to a total redemption price of 100.241 RMB [6][7] - The company will not withhold income tax for certain investors, while individual investors will have a net redemption amount of 100.193 RMB after tax [7] Redemption Rights - Bondholders have the right to redeem either part or all of their unconverted "Kehua Convertible Bonds," and the redemption is not mandatory [8] - The company will publish announcements regarding the redemption conditions, application period, and payment methods in compliance with regulatory requirements [9] Redemption Process - Bondholders must submit their redemption applications through the Shenzhen Stock Exchange trading system during the specified application period [10] - The company will handle the redemption payments through the China Securities Depository and Clearing Corporation [10]
上海科华生物工程股份有限公司关于“科华转债”回售的第四次提示性公告
Core Viewpoint - The announcement details the conditional redemption of "Kehua Convertible Bonds" by Shanghai Kehua Bioengineering Co., Ltd., triggered by specific stock price conditions and outlines the redemption process and terms [1][2][3]. Redemption Conditions - The redemption price is set at 100.241 RMB per bond (including interest and tax) [1][6]. - The triggering date for the redemption conditions is September 5, 2025, when the stock price falls below 70% of the conversion price for 30 consecutive trading days [1][2]. - The redemption is not mandatory, allowing bondholders to choose whether to redeem their bonds [1][7]. Redemption Process - The redemption application period is from September 10 to September 16, 2025 [2][9]. - The funds will be credited to the issuer on September 19, 2025, with the redemption payment date set for September 22, 2025, and investors will receive their funds by September 23, 2025 [2][9]. Interest Calculation - The interest for the redemption is calculated using the formula: IA = B × i × t / 365, where the interest rate (i) is 2.00% for the sixth interest year [4][5]. - The calculated interest per bond is 0.241 RMB, leading to a total redemption price of 100.241 RMB per bond [5][6]. Trading and Conversion Restrictions - During the redemption application period, "Kehua Convertible Bonds" will continue to trade but will not allow conversion into shares [9]. - If bondholders submit multiple requests (trading, conversion, redemption) on the same day, they will be processed in a specific order: trading, redemption, conversion, and transfer [9].
上海科华生物工程股份有限公司关于“科华转债”回售的第三次提示性公告
Core Viewpoint - The announcement details the conditional redemption of "Kehua Convertible Bonds" by Shanghai Kehua Bioengineering Co., Ltd, triggered by specific stock price conditions and outlines the redemption process and terms [1][2][6]. Redemption Conditions - The redemption price is set at 100.241 RMB per bond (including interest and tax) [1][6]. - The triggering date for the redemption conditions is September 5, 2025, when the stock price must be below 70% of the conversion price for 30 consecutive trading days [1][2][4]. Redemption Process - The redemption application period is from September 10 to September 16, 2025 [2][8]. - The funds will be credited to the issuer's account on September 19, 2025, with the redemption payment date set for September 22, 2025, and investors will receive the funds by September 23, 2025 [2][8]. Interest Calculation - The interest for the redemption is calculated based on a rate of 2.00% for the sixth interest period, resulting in an accrued interest of 0.241 RMB per bond [4][5][6]. Tax Implications - Individual investors will have a net redemption amount of 100.193 RMB per bond after a 20% tax deduction, while qualified foreign institutional investors (QFII and RQFII) are exempt from tax [6]. Trading and Conversion Restrictions - During the redemption application period, "Kehua Convertible Bonds" will continue to trade but will not allow conversion into shares [8].
科华生物:关于“科华转债”回售的第三次提示性公告
Zheng Quan Ri Bao· 2025-09-10 14:05
Core Viewpoint - Kewah Bio announced that investors can choose to sell their "Kewah Convertible Bonds" at a price of 100.241 RMB per bond (including interest and tax) [2] Group 1 - The closing price of "Kewah Convertible Bonds" is currently higher than the repurchase price, indicating that investors opting for the repurchase may incur losses [2]
上海科华生物工程股份有限公司 关于“科华转债”回售的公告
Core Viewpoint - The company announced the conditional redemption of its convertible bonds, "Kehua Convertible Bonds," due to the stock price falling below a specified threshold, allowing bondholders to sell their bonds back to the company at a predetermined price [2][18]. Redemption Overview - Redemption Price: The redemption price is set at 100.241 RMB per bond, including interest and tax [2][7]. - Trigger Date: The redemption conditions were triggered on September 5, 2025, when the stock price fell below 70% of the conversion price [2][18]. - Redemption Period: The redemption application period is from September 10 to September 16, 2025 [3][10]. Redemption Terms - Bondholders have the right to redeem all or part of their unconverted bonds at the redemption price, which is the face value plus accrued interest [5][8]. - The accrued interest for the current period is calculated to be 0.241 RMB per bond [6][7]. Redemption Process and Payment - The company will announce the results of the redemption and its impact after the redemption period ends [13]. - Payment Dates: The funds will be credited to the company on September 19, 2025, with the redemption payments to bondholders made on September 23, 2025 [12]. Suspension of Conversion - The conversion of "Kehua Convertible Bonds" will be suspended during the redemption application period from September 10 to September 16, 2025, but trading will continue [17][19].
科华生物: 北京市金杜(广州)律师事务所关于上海科华生物工程股份有限公司可转换公司债券回售的法律意见书
Zheng Quan Zhi Xing· 2025-09-07 08:17
Core Viewpoint - The legal opinion letter issued by King & Wood Mallesons confirms that Shanghai Kehua Bio-engineering Co., Ltd. can proceed with the repurchase of its convertible bonds under specific conditions outlined in the relevant regulations and the offering prospectus [1][9]. Group 1: Legal Framework and Compliance - The legal opinion is based on the Company Law, Securities Law, and relevant regulations, ensuring that the facts presented are true, accurate, and complete [2][3]. - King & Wood Mallesons has conducted thorough verification of the documents related to the bond repurchase, ensuring compliance with legal standards [2][3]. Group 2: Convertible Bond Issuance and Approval - The company received approval from the China Securities Regulatory Commission (CSRC) to issue convertible bonds totaling 738 million yuan, with a maturity of six years [6][7]. - The bonds were listed on the Shenzhen Stock Exchange on August 20, 2020, under the name "Kehua Convertible Bonds" [7]. Group 3: Repurchase Conditions - The offering prospectus stipulates that bondholders can sell their bonds back to the company if the stock price falls below 70% of the conversion price for 30 consecutive trading days during the last two interest periods [8][9]. - The company’s stock price was below the specified threshold of 14.45 yuan per share for the required period, thus triggering the repurchase conditions [8][9]. Group 4: Conclusion and Recommendations - The legal opinion concludes that the company can repurchase the convertible bonds as per the established conditions, provided that the repurchase announcement and results are properly disclosed [9].
科华生物: 中信证券股份有限公司关于上海科华生物工程股份有限公司可转换公司债券回售有关事项的核查意见
Zheng Quan Zhi Xing· 2025-09-07 08:17
Group 1 - The core viewpoint of the article is the verification opinion of CITIC Securities regarding the repurchase of convertible bonds issued by Shanghai Kehua Bio-engineering Co., Ltd. [1][7] - The issuance of Kehua convertible bonds was approved by the China Securities Regulatory Commission, with a total amount of 738 million yuan, and began trading on August 20, 2020 [1][2] - The conversion period for the bonds started on February 3, 2021, and will last until the maturity date on July 27, 2026 [2] Group 2 - The conditional repurchase clause allows bondholders to sell their bonds back to the company if the stock price falls below 70% of the conversion price for 30 consecutive trading days during the last two interest years [2][3] - The conversion price is set at 20.64 yuan per share, and the repurchase price will be the face value plus accrued interest [3][4] - The accrued interest for the sixth interest year is calculated to be 0.241 yuan per bond, resulting in a total repurchase price of 100.241 yuan per bond [5] Group 3 - The repurchase rights are not mandatory, allowing bondholders to choose whether to exercise their right to sell back the bonds [5][6] - The announcement period for the repurchase will begin the trading day after the conditions are met, with daily reminders until the end of the repurchase period [6] - The repurchase period for bondholders to submit their requests is from September 10 to September 16, 2025 [6] Group 4 - The company will continue trading the convertible bonds during the repurchase period but will suspend conversion rights [6] - CITIC Securities has confirmed that the repurchase matters comply with relevant regulations and the terms outlined in the offering prospectus [7]